The Fellowship in Urologic Oncology and Robotic Surgery at Hospital Israelita Albert Einstein (HIAE) in São Paulo offers advanced, hands-on training in the multidisciplinary care of patients with urologic cancers, with strong exposure to contemporary robotic surgical techniques. Fellows participate in high-volume clinical practice, perioperative decision-making, tumor boards, and academic activities, developing expertise across complex oncologic cases and minimally invasive approaches within one of Brazil’s leading tertiary referral centers.
Urologic Oncology
Robotic Surgery in Urology
Willy Baccaglini, MD, MSc, PhD(c), is a board-certified urologist with dedicated expertise in urologic oncology and robotic surgery, currently practicing at Hospital Israelita Albert Einstein in São Paulo, Brazil. His clinical practice is primarily focused on the management of complex urologic malignancies, with particular emphasis on testicular cancer and retroperitoneal lymph node dissection (RPLND), including both open and robot-assisted approaches.
Dr. Baccaglini completed his medical training and residency in urology in Brazil and subsequently pursued advanced academic training, earning a Master’s degree in Health Sciences. He is currently a PhD candidate at the Faculdade de Medicina do ABC, where his doctoral research focuses on centralization of care, learning-curve dynamics, and cost-effectiveness in complex oncologic surgery, particularly robotic RPLND.
At Hospital Israelita Albert Einstein, Dr. Baccaglini works in a high-volume tertiary referral center, actively involved in robotic urologic oncology procedures, perioperative decision-making, and multidisciplinary tumor boards. He plays an active role in surgical education, contributing to the supervision and training of residents and fellows, with a strong commitment to structured, safe adoption of advanced surgical techniques.
Academically, Dr. Baccaglini is engaged in clinical research and outcomes analysis in urologic oncology, with multiple manuscripts under submission or in preparation. His research interests include surgical quality metrics, oncologic outcomes, learning curves in robotic surgery, and the organization of centralized care pathways for rare and complex tumors.
Through his clinical, surgical, and academic activities, Dr. Baccaglini aims to contribute to the development of a robust, academically driven fellowship environment, fostering excellence in patient care, surgical training, and translational research in urologic oncology.
Housing and all living-related expenses are to be arranged and covered by the candidate.
| Duration | Fee |
|---|---|
| 4 weeks | $1,250.00 |
This program allows Merit Applications. This program allows merit-based applications for virtual and onsite clinical and research programs. If you are successfully awarded under this category, Trialect or the host mentor will cover the tuition fee only. All applications will be evaluated based on merit. Due to the high level of competition, the chances of being selected under the merit category are quite limited.
Applicants must be board-certified urologists or have completed an accredited urology residency program at the time of enrollment.
Candidates must demonstrate a strong interest in urologic oncology and robotic surgery.
Availability to commit to the fellowship on a full-time basis for a minimum period of one (1) year is mandatory.
Proficiency in English, Portuguese, or Spanish is required to ensure effective participation in clinical activities, academic discussions, and multidisciplinary meetings.
All candidates must meet institutional and regulatory requirements applicable to clinical observership or fellowship training.
Host Name: Willy Baccaglini
Affiliation: Hospital Israelita Albert Einstein
Address: 627/701 Albert Einstein
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Mar 15th, 2026
| Duration | Fee |
|---|---|
| 4 weeks | $1,250.00 |
This program allows Merit Applications. This program allows merit-based applications for virtual and onsite clinical and research programs. If you are successfully awarded under this category, Trialect or the host mentor will cover the tuition fee only. All applications will be evaluated based on merit. Due to the high level of competition, the chances of being selected under the merit category are quite limited.
Applicants must be board-certified urologists or have completed an accredited urology residency program at the time of enrollment.
Candidates must demonstrate a strong interest in urologic oncology and robotic surgery.
Availability to commit to the fellowship on a full-time basis for a minimum period of one (1) year is mandatory.
Proficiency in English, Portuguese, or Spanish is required to ensure effective participation in clinical activities, academic discussions, and multidisciplinary meetings.
All candidates must meet institutional and regulatory requirements applicable to clinical observership or fellowship training.
Host Name: Willy Baccaglini
Affiliation: Hospital Israelita Albert Einstein
Address: 627/701 Albert Einstein
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.
Commonly asked questions about this program from the host and other attendees.